Skip to content

Application of Remazolam combined with nalbuphine in colonoscopy of obese patients

Application of Remazolam combined with nalbuphine in colonoscopy of obese patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080641
Enrollment
Unknown
Registered
2024-02-04
Start date
2024-02-08
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia of patients undergoing colonoscopy

Interventions

RN group: Remazolam + Nalbuphine:Sedation and anesthesia with remazolam
PN group: Propofol + Nalbuphine:Sedation and anesthesia with Propofol

Sponsors

The Second Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Patients requiring colonoscopy (2) Patients participated in the study knowingly and voluntarily, and signed the informed consent (3) Aged between 18 and 65 (4)ASA classification II-III (5) Body mass index (BMI) =28kg/m^2 (6) When aspirating air (SpO2) > 90%

Exclusion criteria

Exclusion criteria: (1) Difficult airway (there may be factors such as mask difficulty and difficulty in cannulation, such as dentition change, coercive spondylitis, Pierre-Robin syndrome, Mallampati score =?, etc.) (2) Complicated with severe arrhythmia (3) Allergic reaction to the drugs used in this study (4) Patients with contraindications to the drugs used in this study (5) There are serious lung diseases, such as COPD, respiratory failure (6) Patients with severe chronic heart failure (7) Patients with severe hepatic and renal insufficiency (8) Patients with severe chronic pain (9) A history of sedative and analgesic drug dependence (10) Patients with serious mental and nervous system diseases (11) Pregnant women

Design outcomes

Primary

MeasureTime frame
Incidence of hypoxemia;

Secondary

MeasureTime frame
Patient's intraoperative vital signs;Qor-15 scale score;VAS pain score;Recovery time of patients;

Countries

China

Contacts

Public ContactLi Luchen

The Second Affiliated Hospital of Xuzhou Medical University

739318677@qq.com+86 151 5211 7949

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026